Related references
Note: Only part of the references are listed.MDM2's dual mRNA binding domains co-ordinate its oncogenic and tumour suppressor activities
Sivakumar Vadivel Gnanasundram et al.
NUCLEIC ACIDS RESEARCH (2020)
MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors
Maria Letizia Motti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Clinical Development of BRAF plus MEK Inhibitor Combinations
Vivek Subbiah et al.
TRENDS IN CANCER (2020)
Targeting Alterations in the RAF-MEK Pathway
Rona Yaeger et al.
CANCER DISCOVERY (2019)
BRAF Inhibitors in Thyroid Cancer: Clinical Impact, Mechanisms of Resistance and Future Perspectives
Fabiana Crispo et al.
CANCERS (2019)
Phenotype plasticity as enabler of melanoma progression and therapy resistance
Imanol Arozarena et al.
NATURE REVIEWS CANCER (2019)
Molecular targeted therapy: Treating cancer with specificity
Yeuan Ting Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
BTK modulates p73 activity to induce apoptosis independently of p53
Miran Rada et al.
CELL DEATH DISCOVERY (2018)
Current Development Status of MEK Inhibitors
Ying Cheng et al.
MOLECULES (2017)
Selective Targeting of RSK Isoforms in Cancer
Kimberly A. Casalvieri et al.
TRENDS IN CANCER (2017)
p90 ribosomal S6 kinase: a potential therapeutic target in lung cancer
Noufira Poomakkoth et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
P73 tumor suppressor and its targets, p21 and PUMA, are required for madin-darby canine kidney cell morphogenesis by maintaining an appropriate level of epithelial to mesenchymal transition
Yanhong Zhang et al.
ONCOTARGET (2015)
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
Georgina V. Long et al.
NATURE COMMUNICATIONS (2014)
MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
Nikhil Wagle et al.
CANCER DISCOVERY (2014)
The p90 RSK Family Members: Common Functions and Isoform Specificity
Romain Lara et al.
CANCER RESEARCH (2013)
RSK Isoforms in Cancer Cell Invasion and Metastasis
Florian J. Sulzmaier et al.
CANCER RESEARCH (2013)
Ponatinib (AP24534) Is a Novel Potent Inhibitor of Oncogenic RET Mutants Associated With Thyroid Cancer
Valentina De Falco et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer
Violeta Serra et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Targeting the ERBB family in cancer: couples therapy
Niall Tebbutt et al.
NATURE REVIEWS CANCER (2013)
Regulation and function of the RSK family of protein kinases
Yves Romeo et al.
BIOCHEMICAL JOURNAL (2012)
The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches
Antonella De Luca et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells
Rosa Linda Messina et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
PRKX, TTBK2 and RSK4 expression causes sunitinib resistance in kidney carcinoma- and melanoma-cell lines
Claus Bender et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Paving the way for targeting RSK in cancer
Yves Romeo et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Centrosomal and mitotic abnormalities in cell lines derived from papillary thyroid cancer harboring specific gene alterations
Irena Maric et al.
MOLECULAR CYTOGENETICS (2011)
mTOR/S6K1 and MAPK/RSK signaling pathways coordinately regulate estrogen receptor a serine 167 phosphorylation
Rachel L. Yamnik et al.
FEBS LETTERS (2010)
p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells
Sumin Kang et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Transcriptional down-regulation of Bcl-2 by vinorelbine: Identification of a novel binding site of p53 on Bcl-2 promoter
Veronique Bourgarel-Rey et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Gal-3 is stimulated by gain-of-function p53 mutations and modulates chemoresistance in anaplastic thyroid carcinomas
Luca Lavra et al.
JOURNAL OF PATHOLOGY (2009)
RSK Is a Principal Effector of the RAS-ERK Pathway for Eliciting a Coordinate Promotile/Invasive Gene Program and Phenotype in Epithelial Cells
Ulrik Doehn et al.
MOLECULAR CELL (2009)
Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification
Rebecca E. Schweppe et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
P. J. Roberts et al.
ONCOGENE (2007)
MEK-ERK-mediated phosphorylation of Mdm2 at Ser-166 in hepatocytes -: Mdm2 is activated in response to inhibited Akt signaling
Maria Malmlof et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase
Valentina De Falco et al.
CANCER RESEARCH (2007)
The p53-Bcl-2 connection
M. T. Hemann et al.
CELL DEATH AND DIFFERENTIATION (2006)
Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, an E3 ubiquitin ligase
A Toth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
被撤回的出版物: The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells (Retracted article. See vol. 126, pg. 1603, 2016)
RM Melillo et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Essential role of RSK2 in c-Fos-dependent osteosarcoma development
JP David et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation
JH Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Structure and regulation of MAPK phosphatases
A Farooq et al.
CELLULAR SIGNALLING (2004)
ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions
PP Roux et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2004)
Tumorigenesis -: RAF/RAS oncogenes and mismatch-repair status
H Rajagopalan et al.
NATURE (2002)
Coupling cAMP signaling to transcription in the liver: Pivotal role of CREB and CREM
G Servillo et al.
EXPERIMENTAL CELL RESEARCH (2002)
Characterization of regulatory events associated with membrane targeting of p90 ribosomal S6 kinase 1
SA Richards et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
LD Mayo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
